Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
| Autor: | Elewski, Boni E., Okun, Martin M., Papp, Kim, Baker, Christopher S., Crowley, Jeffrey J., Guillet, Gérard, Sundaram, Murali, Poulin, Yves, Gu, Yihua, Geng, Ziqian, Williams, David A., Rich, Phoebe A. |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology January 2018 78(1):90-99 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect